Xiangxin Meng
About Xiangxin Meng
Xiangxin Meng is a Senior Manager, Regulatory CMC at Bristol Myers Squibb with over a decade of experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Xiangxin Meng is currently serving as the Senior Manager, Regulatory CMC at Bristol Myers Squibb. He joined the company in August 2020. In this role, he focuses on regulatory aspects related to Chemistry, Manufacturing, and Controls (CMC), leveraging his extensive experience in the pharmaceutical industry accumulated over more than a decade.
Previous Experience at Sandoz
Before joining Bristol Myers Squibb, Xiangxin Meng worked at Sandoz as part of the Regulatory Affairs team. His tenure at Sandoz was brief, spanning just 5 months in 2020. During this time, he applied his regulatory expertise to support the company's pharmaceutical initiatives.
Regulatory Affairs Manager at Prinston Pharmaceutical Inc.
From 2016 to 2020, Xiangxin Meng served as the Manager of Regulatory Affairs at Prinston Pharmaceutical Inc. Over the course of four years, he was responsible for managing regulatory submissions and ensuring compliance with industry standards and regulations.
Formulation Scientist Roles
Xiangxin Meng has a solid background in formulation science, having worked as a Formulation Scientist at Catalent Pharma Solutions from 2014 to 2016 and at Aquestive Therapeutics from 2012 to 2014. In these positions, he was involved in developing and optimizing pharmaceutical formulations.
Education and Expertise
Xiangxin Meng holds a Doctor of Philosophy (PhD) in Chemistry from the New Jersey Institute of Technology. His educational background laid a strong foundation for his extensive career in the pharmaceutical industry, where he has held multiple roles in both regulatory affairs and formulation science.